Illinois Retina Associates and Assistant Professor, Ophthalmology, Rush University
Encapsulated Cell Therapy for Retinal Diseases
John Pollack, MD, discusses gene therapy advancements for retinal diseases.
NT-501 Cell Therapy Slows Degeneration in Macular Telangiectasia
NT-501 previously received orphan drug and fast track status from the FDA and Neurotech will pursue approval in late 2022.
2 Clarke Drive Cranbury, NJ 08512